These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15723576)

  • 21. [The importance of plasma B-type natriuretic peptide levels in cardiovascular diseases].
    Duygu H; Türk U; Zoghi M; Nalbantgil S
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):305-11. PubMed ID: 16330398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of N-terminal proB-type natriuretic peptide.
    Costello-Boerrigter LC; Burnett JC
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma brain natriuretic peptide levels in the diagnostic and prognostic assessment of patients with heart failure. Pros].
    Metra M; Nodari S; Pedrinazzi C; Rocca P; Manerba A; Vizzardi E; Danesi R; Dei Cas L
    Ital Heart J; 2003 Dec; 4 Suppl 8():59S-67S. PubMed ID: 15005534
    [No Abstract]   [Full Text] [Related]  

  • 24. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.
    Skidmore KL; Russell IA
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):780-7. PubMed ID: 15650995
    [No Abstract]   [Full Text] [Related]  

  • 26. Natriuretic peptides in the diagnosis and management of heart failure.
    Felker GM; Petersen JW; Mark DB
    CMAJ; 2006 Sep; 175(6):611-7. PubMed ID: 16966666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-natriuretic peptide in the management of heart failure.
    Armstrong J; Graber MA
    JAAPA; 2003 Jun; 16(6):35-9, 44. PubMed ID: 14968503
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical uses of brain natriuretic peptide in diagnosing and managing heart failure.
    Anderson KM
    J Am Acad Nurse Pract; 2008 Jun; 20(6):305-10. PubMed ID: 18588657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.
    O'Donoghue M; Januzzi JL
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):487-96. PubMed ID: 15889976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.
    Morello AM; Januzzi JL
    Expert Rev Mol Diagn; 2006 Sep; 6(5):649-62. PubMed ID: 17009901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Natriuretic cardiac hormones. Clinical use in heart failure].
    Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J
    Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain natriuretic peptide: clinical and research challenges.
    Carrillo-Jimenez R; Borzak S; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):85-8. PubMed ID: 17562778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide and acute coronary syndrome.
    Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
    Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.
    Sullivan DR; West M; Jeremy R
    Heart Lung Circ; 2005 Jun; 14(2):78-84. PubMed ID: 16352258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain natriuretic peptide release in cardiac surgery patients.
    Sinha AM; Breithardt OA; Schmid M; Stellbrink C
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):138-43. PubMed ID: 15926091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natriuretic peptides in heart failure.
    Richards AM
    Basic Res Cardiol; 2004 Mar; 99(2):94-100. PubMed ID: 14963668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
    Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
    Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.